文献速递脑血管病

溶栓后急诊颈动脉支架联合取栓治疗串联卒中的安全性:TITAN登记分析

Emergent Carotid Stenting Plus Thrombectomy After Thrombolysis in Tandem Strokes: Analysis of the TITAN Registry.
PubMed 文献 · Stroke · 2019-06-17

基于多中心TITAN登记,评估急性前循环串联闭塞患者接受急诊颈动脉支架联合机械取栓时,术前静脉溶栓是否增加出血风险;205例中125例接受溶栓,症状性颅内出血率无显著差异,90天全因死亡率溶栓组更低。

要点

  • 术前静脉溶栓未增加症状性颅内出血风险。
  • 溶栓组90天全因死亡率显著低于未溶栓组。
  • 调整协变量后,溶栓与症状性颅内出血或90天死亡率无关。

核心结论

  • 急诊颈动脉支架联合机械取栓未增加术前接受静脉溶栓的串联闭塞患者的出血并发症风险。

研究设计与样本

  • 多中心观察性TITAN登记研究,纳入因动脉粥样硬化性串联闭塞接受急诊颈动脉支架联合机械取栓的急性缺血性卒中患者205例,按术前是否静脉溶栓分为两组。

主要发现

  • 205例中125例(60%)接受术前静脉溶栓。
  • 溶栓组症状性颅内出血发生率5%,未溶栓组8%(P=0.544)。
  • 溶栓组90天全因死亡率8%,未溶栓组20%(P=0.017)。
  • 两组成功再灌注(mTICI 2b–3)和90天良好功能结局(mRS 0–2)无显著差异。
  • 调整协变量后,静脉溶栓与症状性颅内出血或90天死亡率无关。

关键数值与推荐

  • 颅内出血按欧洲急性卒中协作研究II(ECASS II)标准分类。
  • 成功再灌注定义为改良脑缺血溶栓评分(mTICI)2b–3。
  • 90天良好结局定义为改良Rankin量表(mRS)评分0–2。

临床怎么用

  • 对于前循环串联闭塞患者,术前静脉溶栓后行急诊颈动脉支架联合机械取栓可能是安全的。

局限性

  • 本研究为观察性登记分析,可能存在选择偏倚和未测量混杂因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Emergent carotid artery stenting plus mechanical thrombectomy is an effective treatment for acute ischemic stroke patients with tandem occlusion of the anterior circulation. However, there is limited data supporting the safety of this approach in patients treated with prior intravenous thrombolysis (IVT). We aimed to investigate the safety of emergent carotid artery stenting-mechanical thrombectomy approach in stroke patient population treated with prior IVT METHODS: —We assessed patients with acute ischemic stroke because of atherosclerotic tandem occlusion that were treated with emergent carotid artery stenting-mechanical thrombectomy approach from the multicenter observational Thrombectomy in Tandem Lesions registry. Patients were divided into 2 groups based on pretreatment IVT (IVT versus no-IVT). Intracerebral hemorrhages were classified according to the European Cooperative Acute Stroke Study II criteria. RESULTS: Among 205 patients included in the present study, 125 (60%) received prior IVT. Time from symptoms onsetto-groin puncture was shorter (234±100 versus 256±234 minutes; P=0.002), and heparin use was less in the IVT group (14% versus 35%; P<0.001); otherwise, there was no difference in the baseline characteristics. There was no significant difference between the IVT and no-IVT groups in the rate of symptomatic intracerebral hemorrhage (5% versus 8%; P=0.544), parenchymal hematoma type 1 to 2 (15% versus 18%; P=0.647), successful reperfusion (modified Thrombolysis in Cerebral Ischemia 2b–3), or 90-day favorable outcome (modified Rankin Scale score of 0–2 at 90 days). The 90-day all-cause mortality rate was significantly lower in the IVT group (8% versus 20%; P=0.017). After adjusting for covariates, IVT was not associated with symptomatic intracerebral hemorrhage or 90-day mortality CONCLUSIONS: Emergent carotid artery stenting-mechanical thrombectomy approach was not associated with an increased risk of hemorrhagic complications in tandem occlusion patients who received IVT before the intervention.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Anadani M, Spiotta AM, Alawieh A, et al. Emergent Carotid Stenting Plus Thrombectomy After Thrombolysis in Tandem Strokes: Analysis of the TITAN Registry. Stroke. 2019. PMID: 31577899. doi:10.1161/STROKEAHA.118.024733

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。